Reddy Drugs Laboratories
He started his long and illustrious career in the Biopharma industry at G.D. Searle & Co. In 1986 he joined ZymoGenetics as Vice President of Research and Development and then went on to head the company as Chief Executive Officer from April 1998 to January 2009. During this period ZymoGenetics was acquired by Novo Nordisk A/S where he served as Corporate Executive Vice President and Chief Scientific Officer from April 1994 to October 1999. Dr. Carter led the negotiations that established ZymoGenetics as an independent company from Novo Nordisk in 2000. He has also been the part of academia, as a Lecturer/Professor at Trinity College, University of Dublin and University of Washington. Dr. Carter received a B.Sc. with Honors in Botany from the University of Nottingham, England, and a Ph.D. in Microbiology from Queen Elizabeth College, University of London.
Research and Development